Annual report pursuant to Section 13 and 15(d)

ACQUISITION (Tables)

v3.8.0.1
ACQUISITION (Tables)
12 Months Ended
Dec. 31, 2017
Business Combinations [Abstract]  
Fair value of assets acquired and liabilities assumed

The fair value of the assets acquired and liabilities assumed from Beijing GenExosome are as follows:

 

    October 25, 2017  
Assets acquired:        
Cash   $ 72,032  
Inventory     1,081  
Prepaid expenses     142  
Security deposit     753  
Property, plant and equipment     3,346  
Intangible assets - goodwill     397,569  
Total assets     474,923  
Liabilities assumed:        
Accrued liabilities and other payables     24,923  
Total liabilities     24,923  
Purchase price   $ 450,000  
Business Acquisition, Pro Forma Information

The following unaudited pro forma consolidated results of operations have been prepared as if the acquisition of Beijing GenExosome had occurred as of the beginning of the following periods:

 

    Year Ended December 31, 2017     Year Ended December 31, 2016  
Net revenues   $ 1,077,550     $ 671,863  
Net loss   $ (4,171,807 )   $ (405,983 )
Net loss attributable to Avalon GloboCare Corp.   $ (3,561,650 )   $ (420,879 )
Net loss per share   $ (0.05 )   $ (0.01 )